Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Latest News about ESALF Recent news which mentions ESALF < Previous 1 2 Next > Biogen's Alzheimer's Drug Secures UK Approval, But An Independent Agency Does Not Recommend Reimbursement August 22, 2024 Tickers BIIB ESAIY ESALF NEWS Tags General Briefs News From Benzinga Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events July 26, 2024 Tickers BIIB ESALF ESALY LLY Tags Market News LLY Benzinga From Benzinga Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings' July 15, 2024 Tickers BIIB BMY ESALF JNJ Tags Politics JNJ ESALF From Benzinga Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst July 03, 2024 Tickers BIIB ESAIY ESALF LLY Tags Analyst Color Stories That Matter News From Benzinga Why Is Eli Lilly Stock Trading Higher Premarket Tuesday? June 11, 2024 Tickers BIIB ESALF LLY NEWS Tags Market News Media LLY From Benzinga European Medicines Agency Delays Approval Decision For Biogen-Eisai Partnered Alzheimer's Drug Lecanemab March 22, 2024 Tickers BIIB ESALF ESALY NEWS Tags Benzinga Market News BIIB From Benzinga Merck, Eisai Report Yet Another Failure For Keytruda Plus Lenvima Combo Trial, This Time In Endometrial Cancer December 08, 2023 Tickers ESALF ESALY MRK Tags Large Cap Biotech Health Care From Benzinga Biogen quarterly results top estimates despite complex launch of new Alzheimer’s treatment November 08, 2023 Tickers BIIB ESALF SPX Tags ESALF SPX BIIB From MarketWatch Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming November 06, 2023 Tickers BIIB ESALF JNJ LLY Tags BIIB JNJ MRK From MarketWatch Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge November 02, 2023 Tickers BIIB ESALF LLY SPX Tags SPX ESALF LLY From MarketWatch Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake October 25, 2023 Tickers BIIB ESALF LLY Tags ESALF LLY BIIB From MarketWatch Improved Alzheimer's Diagnosis Access: CMS Expands Amyloid PET Scan Usage October 13, 2023 Tickers BIIB ESALF ESALY LLY Tags ESALF Briefs News From Benzinga LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly October 10, 2023 Tickers BIIB ESALF ESALY LLY Tags Market News LLY Benzinga From Benzinga Amazon Invests $4B In ChatGPT Competitor, Hollywood Writers Accept Tentative Deal, ChatGPT Challenges Siri And Alexa With Introduction Of Verbal Responses: Today's Top Stories September 25, 2023 Tickers AA AAPL AMZN BIIB Tags News MBGAF MA From Benzinga Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi September 25, 2023 Tickers BIIB ESALF ESALY Tags General Health Care BIIB From Benzinga Merck-Eisai Partnered Two Keytruda/Lenvima Combo Trials Flunk In Certain Types Of Lung Cancer September 22, 2023 Tickers ESALF ESALY MRK Tags Large Cap Biotech Health Care From Benzinga Merck/Eisai's Cancer Combo Therapy Ambition Dashed Once Again, Companies Throw Towel On Head & Neck Trial August 25, 2023 Tickers ESALF ESALY MRK Tags General News Briefs From Benzinga Quest Diagnostics launches first at-home blood test to assess risk of developing Alzheimer’s disease July 31, 2023 Tickers BIIB DGX ESALF LLY Tags LLY BIIB DGX From MarketWatch Biogen to slash 1,000 jobs as it looks to save $700 million July 25, 2023 Tickers BIIB ESALF LLY SAGE Tags SPX ESALF LLY From MarketWatch At-home Alzheimer’s testing is on the horizon, researchers say July 19, 2023 Tickers BIIB ESALF LLY Tags BIIB LLY ESALF From MarketWatch Eli Lilly’s Alzheimer’s treatment shows promise in early stages of disease — but safety concerns remain July 17, 2023 Tickers BIIB ESALF LLY SPX Tags ESALF SPX BIIB From MarketWatch Expanded Medicare Coverage For Biogen-Eisai's Leqembi Signals a Turning Point in Alzheimer's Treatment: Analysts July 07, 2023 Tickers BIIB ESALF ESALY Tags Biotech Health Care BIIB From Benzinga Biogen’s big Alzheimer’s drug win fails to boost the stock as analysts see slow Leqembi rollout July 07, 2023 Tickers BIIB ESALF LLY Tags ESALF LLY BIIB From MarketWatch FDA approves Alzheimer’s treatment Leqembi, clearing the way for Medicare coverage July 06, 2023 Tickers BIIB ESALF LLY Tags ESALF LLY BIIB From MarketWatch Alzheimer's Drug Leqembi Faces Hurdles in Europe: Concerns Over Health Risks and Healthcare Resources June 13, 2023 Tickers BIIB ESALF ESALY Tags ESALF Markets Top Stories From Benzinga Prospects for Full Approval of Eisai and Biogen's Leqembi Shine Brighter after FDA Committee Vote June 12, 2023 Tickers BIIB ESALF ESALY Tags Briefs News ESALY From Benzinga Goldman pushes back against bearish Morgan Stanley’s Mike Wilson with new 4,500 S&P 500 target June 12, 2023 Tickers AAPL AMC AMD AMZN Tags CCF NQ00 SPX From MarketWatch Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move June 12, 2023 Tickers BIIB CCF CVNA ESALF Tags ILMN ESALF TECK From MarketWatch FDA advisers vote in favor of Biogen and Eisai’s collaborative Alzheimer’s treatment June 09, 2023 Tickers BIIB ESALF Tags ESALF BIIB From MarketWatch Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable' June 08, 2023 Tickers BIIB ESALF ESALY Tags Briefs News Regulations From Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.